SOPH Earnings Date: Nov 3, 2026 (Estimated) — SOPHiA GENETICS S.A.
NASDAQ · Healthcare · Health Information Services
Updated
When is SOPH's next earnings date?
SOPHiA GENETICS S.A. (SOPH) is expected to report Q3 2026 earnings on Tuesday, November 3, 2026 at 6:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.20 on revenue of $24.0M.
How did SOPH do in its last earnings report?
In its most recent report on Aug 4, 2026 (Q2 2026), SOPHiA GENETICS S.A. posted EPS of -$0.30 versus the -$0.22 estimate, a miss of 36.4%. Revenue was $23.3M against a $21.6M estimate. The stock's 1-day post-earnings move was +20.2%.
How much does SOPH stock move after earnings?
SOPH beat EPS estimates in 1 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 7.6% (up or down) in the day after earnings.
About SOPHiA GENETICS S.A.
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 | Q2 2026 | -0.22 | -0.30 | -36.36% | $23.3M | ❌ Miss | +20.21% | +34.80% | +48.07% |
| 2026-05-05 | Q1 2026 | -0.24 | -0.27 | -12.50% | $21.7M | ❌ Miss | -4.16% | -9.45% | -9.64% |
| 2026-03-03 | Q4 2025 | -0.20 | -0.28 | -40.00% | $21.7M | ❌ Miss | -11.26% | -3.46% | +7.14% |
| 2025-11-04 | Q3 2025 | -0.20 | -0.30 | -50.00% | $19.5M | ❌ Miss | -6.40% | -13.00% | -1.60% |
| 2025-08-05 | Q2 2025 | -0.17 | -0.33 | -94.12% | $18.3M | ❌ Miss | +3.64% | -8.79% | +3.94% |
| 2025-03-04 | Q4 2024 | -0.15 | -0.23 | -53.33% | $17.7M | ❌ Miss | -13.17% | -10.08% | -11.20% |
| 2024-11-05 | Q3 2024 | -0.23 | -0.28 | -21.74% | $15.9M | ❌ Miss | +0.00% | +1.07% | -9.47% |
| 2024-08-06 | Q2 2024 | -0.28 | -0.23 | +17.86% | $15.8M | ✅ Beat | -2.17% | -23.13% | -9.40% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q4 FY23 · $47.3M total
| Segment | Share | Revenue | YoY | Q4 FY23 |
|---|---|---|---|---|
| Europe, The Middle East And Africa | 70.1% | $33.2M | — | $33.2M |
| North America | 17.4% | $8.2M | — | $8.2M |
| Latin America | 6.5% | $3.1M | — | $3.1M |
| Asia Pacific | 6.0% | $2.9M | — | $2.9M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.